StockGlow

Fusion Antibodies plc (FAB.L)

Fusion Antibodies plc, a contract research organization, engages in the research, development, and manufacture of recombinant proteins and antibodies for cancer and infectious diseases in the United Kingdom, the rest of Europe, North America, and internationally.

9.75+0.00%Healthcare
Compare FAB.L with
StockGlow Score
6
Bearish
BearishBullish
1 year ago-11.4%

The outlook

Fusion Antibodies plc currently reads as bearish based on below its 50- & 200-day averages, 6% of the way from its 52-week low to high. This is a snapshot of current market data, not a forecast.

What’s behind the score

Price trendBelow its 50- & 200-day averages
52-week range6% of the way from its 52-week low to high
Market cap
$12.2M
52-wk high
21.00
52-wk low
9.00
50-day avg
11.68
200-day avg
13.25
Trailing P/E
—

Similar stocks

GDR.Lgenedrive plc$1.00-4.76%HEMO.LHemogenyx Pharmaceuticals Plc$614.50-2.85%VAL.LValiRx plc$0.15+0.00%IMM.LImmuPharma plc$3.58-3.24%AVCT.LAvacta Group Plc$66.50-2.06%

The StockGlow Score is a snapshot of current, observable market data (analyst ratings, price trend, 52-week range) — not a prediction, forecast, or recommendation. Informational only, not investment advice. Data from public sources and may be delayed. How this works·Privacy